PATENT CLAIM ANALYSIS

Application Number: 16053412
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-11
Patent Classification: ["514", "183000"]

Abstract:
Described are a group of isoxazol-3(2H)-one analogues and their use in topical formulations for the treatment and prophylaxis of dermatological disorders.

Claim (Index 15):
The method according to  claim 12  characterized in that the dermatologically acceptable carrier is composed of propylene glycol and/or glycerol, vaselinum album, paraffinum liquidum, cetostrearyl alcohol, cetomacrogol 1000, chlorocresol or bensylalcohol, sodium dihydrogen phosphate dehydrate, concentrated phosphoric acid (85%) and distilled water.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 96.0
- Lexical Diversity: 1.08333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12755010', '14778046', '11737069', '11595187', '14345982']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7853524575274645
- 35 USC 102 Novelty (BERT): 0.500678969103603
- Combined Prediction Score: 0.7568851086850784
- Mean Citation Score: 218.8076
- Max Citation Score: 229.31332
- Similarity Product: 154.61489024872304

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test